J&J Expected To Beat Rivals With Release Of Drug-Coated Stents

03/18/2002 | CNN · Yahoo/Reuters

Johnson & Johnson yesterday unveiled new data that show its antibiotic-coated stent prevents heart arteries from reclogging after 12 months of implantation. The company's Cordis unit is expected to market the device by 2003, six months before its rivals release their solutions. Doctors say the device will help patients needing a repeat procedure.

View Full Article in:

CNN · Yahoo/Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC
Director of Program Development
AdvaMed
Washington DC, DC
Director of System QA
LifeWatch Services, Inc.
Rosemont, IL
Director of Business Development and Membership
AdvaMed
Washington DC, DC
Vice-President of Technology and Regulatory Affairs
AdvaMed
Washington DC, DC